Matilda Pharmaceuticals (India) Private Limited - Company Profile

It is a pharma private limited company based in Kankavli, Maharashtra, India, established in 2014.
2014 Kankavli, Maharashtra, India Active
Last Updated:
Access Report
About Matilda Pharmaceuticals (India) Private Limited

Matilda Pharmaceuticals (India) Private Limited, a active private limited company, was established on 15 July 2014 in Kankavli, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24200PN2014PTC151822. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sameer Madhukar Navare (Director), Virendra Shivram Nachane (Director). It holds ₹1.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 1, 9, 10, Second Floor, Mudra Apts. Nr. S.M.Highschool, Above Hotel Mintleaf, ,, Kankavli, Maharashtra, 416602.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24200PN2014PTC151822

  • Registration Number

    151822

  • Incorporation Date

    15 July 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.15 Cr
  • Revenue Growth **** -5.84%
  • Profit Growth **** -9.24%
  • Ebitda **** -2.54%
  • Net Worth 15.27%
  • Total Assets **** 1.30%
Company report

Matilda Pharmaceuticals (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Matilda Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Matilda Pharmaceuticals (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Sameer Madhukar Navare Director 15 Jul 2014 Current
Virendra Shivram Nachane Director 15 Jul 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Matilda Pharmaceuticals (India).

Matilda Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.84% decrease. The company also saw a slight decrease in profitability, with a 9.24% decrease in profit. The company's net worth Soared by an impressive increase of 15.27%.

Matilda Pharmaceuticals (India) revenue growth over time
Matilda Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -5.84%
*******
*******
*******
*******
Revenue from Operations
*******
 -5.94%
*******
*******
*******
*******
Total Assets
*******
 1.30%
*******
*******
*******
*******
Profit or Loss
*******
 -9.24%
*******
*******
*******
*******
Net Worth
*******
 15.27%
*******
*******
*******
*******
EBITDA
*******
 -2.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Matilda Pharmaceuticals (India)?

In 2021, Matilda Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹11,483,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.90 Cr
  • Uco Bank : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
07 Feb 2018 Others ₹0.50 M Open
06 Feb 2018 Others ₹8.48 M Open
27 Jun 2016 Uco Bank ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Matilda Pharmaceuticals (India)?

Unlock and access historical data on people associated with Matilda Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Matilda Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Matilda Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Matilda Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    Matilda Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Matilda Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Charges

    The activity A charge with Uco Bank of Rs. 2.50 M registered on 27 Jun 2016 with Charge ID 100039629 was modified on 02 Jan 2020. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 0.50 M with Charge ID 100158258 was registered on 07 Feb 2018. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 8.48 M with Charge ID 100158204 was registered on 06 Feb 2018. was documented.

  • Charges

    Progress on A charge with Uco Bank amounted to Rs. 2.50 M with Charge ID 100039629 was registered on 27 Jun 2016. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Matilda Pharmaceuticals (India) Private Limited?

The CIN of Matilda Pharmaceuticals (India) Private Limited is U24200PN2014PTC151822.

Where is Matilda Pharmaceuticals (India) Private Limited headquartered?

Matilda Pharmaceuticals (India) Private Limited is headquartered at Shop No. 1, 9, 10, Second Floor, Mudra Apts. Nr. S.M.Highschool, Above Hotel Mintleaf, ,, Kankavli, Maharashtra, 416602.

When was Matilda Pharmaceuticals (India) Private Limited incorporated?

Matilda Pharmaceuticals (India) Private Limited was incorporated on 15 July 2014.

Who are the current directors of Matilda Pharmaceuticals (India) Private Limited?

The current directors of Matilda Pharmaceuticals (India) Private Limited are

What is the primary industry of Matilda Pharmaceuticals (India) Private Limited?

The primary industry of Matilda Pharmaceuticals (India) Private Limited is Trade.

Is Matilda Pharmaceuticals (India) Private Limited a listed company?

Matilda Pharmaceuticals (India) Private Limited is unlisted.

What is the capital structure of Matilda Pharmaceuticals (India) Private Limited?

The authorized capital of Matilda Pharmaceuticals (India) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Matilda Pharmaceuticals (India) Private Limited?

The compliance status of Matilda Pharmaceuticals (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available